Advanced Biomed is trading at $5.00, down 19.48% in after-hours trading, with no confirmed company-specific announcement explaining the move.

  • Shares fell sharply after the October 7 regular-session close; broader-market declines were modest and do not clearly explain the move.
  • The latest identified company news is a September 28 notice that it could not file its annual 10-K by the SEC deadline. That earlier notice does not establish the cause of this drop.